STK4
STK4 (serine/threonine kinase 4, also known as MST1, KRS2 and YSK3) is a stress-activated, pro-apoptotic serine/threonine kinase and a core component of the Hippo signalling pathway. It restricts proliferation and promotes apoptosis, contributing to organ size control and tumour suppression. Browse Assay Genie's current range of STK4 research reagents below, or read on for the biology behind the target.
STK4 is a serine/threonine kinase that acts as a stress-activated, pro-apoptotic signalling protein. Following caspase cleavage, it enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation. A caspase-cleaved fragment phosphorylates histone H2B, specifically Ser-14 during apoptosis, a modification correlated with cell death. The kinase also undergoes autophosphorylation and can phosphorylate myelin basic protein.
In the Hippo pathway, STK3/MST2 and STK4/MST1 form a complex with the regulatory protein SAV1 and phosphorylate and activate LATS1/2, which act with MOB1. LATS kinases in turn phosphorylate and inactivate the YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS2 prevents its nuclear translocation, limiting expression of genes involved in proliferation, cell death and migration. STK3 and STK4 are required to repress proliferation of mature hepatocytes, prevent activation of facultative adult liver stem cells (oval cells) and inhibit tumour formation.
Other reported substrates broaden its role. STK4 phosphorylates FOXO3 on oxidative stress, driving nuclear translocation and cell death initiation, and phosphorylates FOXO1 on Ser-212 to stimulate PMAIP1 transcription. It phosphorylates SIRT1, inhibiting SIRT1-mediated p53 deacetylation and promoting p53-dependent transcription and apoptosis after DNA damage. It also phosphorylates MOBKL1A, MOBKL1B, RASSF2 and cardiac troponin I (TNNI3), acts as an inhibitor of PKB/AKT1, and phosphorylates the androgen receptor on Ser-650 to suppress its activity.
The STK4 gene encodes a cytoplasmic kinase structurally similar to yeast Ste20p, which acts upstream of the stress-induced MAP kinase cascade. It belongs to the STE20 subfamily of the STE Ser/Thr protein kinase family and to the HGNC STK3/STK4 kinase family. The mouse ortholog is Stk4.
STK4 phosphorylates and activates LATS1/2 with SAV1 and MOB1, leading to inactivation of YAP1 and WWTR1/TAZ.
Caspase-cleaved STK4 enters the nucleus, phosphorylates histone H2B at Ser-14 and induces chromatin condensation and DNA fragmentation.
STK3 and STK4 restrict proliferation, repress hepatocyte growth, keep oval cells inactive and inhibit tumour formation in the liver.
STK4 phosphorylates FOXO3, FOXO1 and SIRT1, linking oxidative stress and DNA damage to cell death and p53 activity.
STK4 is a stress-activated, pro-apoptotic serine/threonine kinase. In the Hippo pathway it phosphorylates and activates LATS1/2, which inactivate YAP1 and WWTR1/TAZ to restrict proliferation. After caspase cleavage it enters the nucleus, phosphorylates histone H2B and induces chromatin condensation during apoptosis.
STK4 (serine/threonine kinase 4) is also called MST1, KRS2 and YSK3. UniProt lists it as serine/threonine-protein kinase 4. Literature often pairs STK4/MST1 with STK3/MST2, its close relative in the STK3/STK4 kinase family and the STE20 subfamily.
The mouse ortholog is Stk4. The kinase is a Hippo pathway component with roles in tumour suppression, and STK3 and STK4 together are required to inhibit tumour formation in the liver. Check the datasheet of any product for its validated reactivity.
Other serine/threonine kinases, including the Hippo pathway partner STK3 and STE20 family members.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q13043; product specifications from Assay Genie datasheets.